ASTH — Astrana Health, Inc.

Nasdaq · Unknown · Unknown · CIK 1083446 ·
Last close
$38.54
Market Cap
$1.91B
52W High
$39.93
52W Low
$20.27
ADV30
487,656
Next earnings
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 965,100,000 105,744,000 28,528,000 14,436,000 2,358,827,000 478,383,000 1,781,371,000
Dec 2025 950,526,000 95,043,000 18,395,000 5,999,000 2,218,661,000 429,474,000 1,660,327,000
Sep 2025 956,048,000 97,192,000 19,210,000 373,000 2,237,186,000 462,227,000 1,682,462,000
Jun 2025 654,808,000 77,969,000 20,340,000 9,423,000 1,442,350,000 339,703,000 904,404,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$114,597,000
Investing CF
$-538,999,000
Financing CF
$569,346,000
CapEx
$-10,106,000
Dividends Paid
$-7,885,000
Buybacks
$-2,253,000
EPS Diluted TTM
$0.46
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$308,379,000
Inventory
Receivables
$407,575,000
ST Investments
$1,221,000
EBIT TTM
$89,534,000
Pretax Income TTM
$39,606,000
Interest Exp TTM
$49,928,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,526,479,104
EBITDA
$159,623,008
Free Cash Flow
$287,761,888
Enterprise Value
$2,240,729,344
Total Cash
$478,383,008
Total Debt
$1,065,192,000
Shares Out
49,583,418
Trailing EPS
$0.61
Book Value
$16.35
ROE
5.7%
ROA
3.6%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 3,181,769,000 78,525,000 22,487,000 2,218,661,000 1,660,327,000 114,597,000
Dec 2024 2,034,540,000 89,350,000 43,149,000 1,354,894,000 840,726,000 52,198,000
Dec 2023 1,386,661,000 84,613,000 60,717,000 933,361,000 522,593,000 68,227,000
Dec 2022 1,144,163,000 104,265,000 45,171,000 966,213,000 407,666,000 82,128,000
Dec 2021

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$3.41

Max Pain — expiry 2026-06-18

max pain strike: $35.00 · spot: $38.54 · call oi: 4,546 · put oi: 37

News headlines (Yahoo Finance, 1h cache)

A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
2026-05-26 18:23 · Yahoo
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)?
2026-05-21 21:16 · Yahoo
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
2026-05-21 03:08 · Yahoo
2 Mooning Stocks Worth Investigating and 1 We Question
2026-05-19 05:16 · Yahoo
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call
2026-05-17 15:32 · Yahoo
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results
2026-05-14 16:53 · Yahoo
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
2026-05-13 18:44 · Yahoo
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations
2026-05-13 03:07 · Yahoo
ASTH Q1 Deep Dive: AI-Enabled Platform, Full-Risk Expansion, and Operating Leverage Shape Results
2026-05-12 23:56 · Yahoo
Astrana Health, Inc. Announces Appointment of Interim National Medical Director
2026-05-12 20:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.